Hyperprolactinemia.
Thapa S, Bhusal K.
2023 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Hyperprolactinemia: pathophysiology and therapeutic approach.
Capozzi A, Scambia G, Pontecorvi A, Lello S.
Gynecol Endocrinol. 2015 Jul;31(7):506-10. doi: 10.3109/09513590.2015.1017810. Epub 2015 Jul 6.
Antipsychotic-induced hyperprolactinemia.
Bostwick JR, Guthrie SK, Ellingrod VL.
Pharmacotherapy. 2009 Jan;29(1):64-73. doi: 10.1592/phco.29.1.64.
Prolactin's diverse physiological roles and the clinical significance of hyperprolactinemia.
Bocianska K, Bochynski H, Markwitz M, Katulski K.
Ginekol Pol. 2025;96(9):787-792. doi: 10.5603/gpl.105311. Epub 2025 Jun 9.
Hyperprolactinemia.
Majumdar A, Mangal NS.
J Hum Reprod Sci. 2013 Jul;6(3):168-75. doi: 10.4103/0974-1208.121400.
Metabolic effects of prolactin.
Pirchio R, Graziadio C, Colao A, Pivonello R, Auriemma RS.
Front Endocrinol (Lausanne). 2022 Sep 27;13:1015520. doi: 10.3389/fendo.2022.1015520. eCollection 2022.
Overview of Hyperprolactinemia: General Approach and Reproductive Health Implications.
Haidenberg-David F, Sidauy-Adissi J, Moscona-Nissan A, Jonguitud-Zumaya E, Fugarolas-Morinelli M, Martinez-Mendoza F, Taniguchi-Ponciano K, Marrero-Rodríguez D, Mercado M.
Arch Med Res. 2024 Dec;55(8):103102. doi: 10.1016/j.arcmed.2024.103102. Epub 2024 Oct 24.
Hyperprolactinaemia.
Samperi I, Lithgow K, Karavitaki N.
J Clin Med. 2019 Dec 13;8(12):2203. doi: 10.3390/jcm8122203.
Neuroleptic-induced hyperprolactinemia.
Dickson RA, Glazer WM.
Schizophr Res. 1999 Mar 1;35 Suppl:S75-86. doi: 10.1016/s0920-9964(98)00159-5.
Sexual function in altered physiological states: comparison of effects of hypertension, diabetes, hyperprolactinemia, and others to "normal" aging in male rats.
Clark JT.
Neurosci Biobehav Rev. 1995 Summer;19(2):279-302. doi: 10.1016/0149-7634(94)00058-9.
